Wealthspire Advisors (New York)’s Rockwell Medical RMTI Stock Holding History

Wealthspire Advisors (New York)’s Portfolio RMTI Stock Details RMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$83.6K	Hold	15,184	–	–	﹤0.01%	1239
2026 Q1	$136K	Buy	+15,184	New	+$151K	﹤0.01%	887
2025 Q4	–	Sell	-1,005	Closed	-$12.1K	–	2483
2025 Q3	$12.1K	Hold	1,005	–	–	﹤0.01%	1922
2025 Q2	$8.52K	Hold	1,005	–	–	﹤0.01%	846
2025 Q1	$11.4K	Hold	1,005	–	–	﹤0.01%	786
2024 Q4	$20.5K	Buy	+1,005	New	+$29.3K	﹤0.01%	787

Other funds holding RMTI

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

Wealthspire Advisors (New York)'s RMTI Position: Q2 2026 in Review

Wealthspire Advisors (New York) held its Rockwell Medical (RMTI) position steady in Q2 2026 at 15,184 shares worth $83.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

Wealthspire Advisors (New York) first reported a position in RMTI in Q4 2024 and has held it in 6 quarters since. The position peaked at $136K in Q1 2026. 37 funds tracked by Wall St. Rank hold RMTI as of Q2 2026.

Wealthspire Advisors (New York) held 15,184 shares of Rockwell Medical worth $83.6K as of Q2 2026.
Wealthspire Advisors (New York) left its Rockwell Medical share count unchanged in Q2 2026.
Rockwell Medical made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #1239 holding.
Wealthspire Advisors (New York) first reported a position in Rockwell Medical in Q4 2024 and has held it in 6 quarters since.
Wealthspire Advisors (New York)'s Rockwell Medical position peaked at $136K in Q1 2026.
37 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.